menu search

belite bio (blte) stock surges 72% in a month: here's why

belite Bio (BLTE) rises 72% in a month due to encouraging progress on the development of the company's ...

August 21, 2023, 12:47 pm

belite bio, inc (blte) q2 2023 earnings call transcript

belite Bio, Inc (NASDAQ:BLTE ) Q2 2023 Earnings Conference Call August 9, 2023 4:30 PM ET Company Parti...

August 13, 2023, 9:45 am

belite bio doses first subject in pivotal phase 3 phoenix trial evaluating oral tinlarebant for ga

Tinlarebant (a/k/a LBS-008) is belite Bio’s orally administered tablet intended to slow disease progr...

July 27, 2023, 9:00 pm

belite bio completes enrollment in pivotal global phase 3 dragon trial evaluating oral tinlarebant for stargardt disease

Tinlarebant (a/k/a LBS-008) is belite Bio’s orally administered tablet intended to slow disease progr...

July 24, 2023, 10:04 am

Why shares of belite bio soared this week

Investors, seeing the 52-week low, saw a bargain in belite Bio. The company doesn't have any revenue, b...

June 30, 2023, 4:09 pm

belite bio: undercovered eye disease company with early data

BLTE works with retinal disease patients. Their lead asset has positive phase 1 data. Their cash position and trial patient population are two worries...

June 15, 2023, 12:34 pm

Top 5 health care stocks that are set to fly in q2 - clearpoint neuro (nasdaq:clpt), belite bio (nasdaq:blte)

The most oversold stocks in the health care sector presents an opportunity to buy into undervalued companies....

June 9, 2023, 8:40 am

Why shares of belite bio are slumping wednesday

belite Bio is a clinical-stage biopharmaceutical company focusing on rare eye diseases and other metabo...

May 31, 2023, 12:22 pm

belite bio announces pricing of $30 million underwritten public offering of american depositary shares and warrants

SAN DIEGO, May 30, 2023 (GLOBE NEWSWIRE) — belite Bio, Inc (NASDAQ: BLTE) (“...

May 31, 2023, 12:49 am

belite bio, inc (blte) q1 2023 earnings call transcript

belite Bio, Inc (NASDAQ:BLTE ) Q1 2023 Earnings Conference Call May 11, 2023 8:00 AM ET Company Partici...

May 14, 2023, 4:42 am

belite bio to host webcast on may 11, 2023 to discuss first quarter 2023 financial results

SAN DIEGO, May 10, 2023 (GLOBE NEWSWIRE) -- belite Bio, Inc (NASDAQ: BLTE), a clinical stage biopharmac...

May 10, 2023, 3:33 pm

belite bio, inc (blte) q4 2022 earnings call transcript

belite Bio, Inc (NASDAQ:BLTE ) Q4 2022 Earnings Conference Call April 3, 2023 4:30 PM ET Company Partic...

April 3, 2023, 8:39 pm

belite bio reports full-year 2022 operational highlights and financial results

12-month interim data from the ongoing 2-year, Phase 2 Stargardt disease (STGD1) study continues to show halting or slowing of lesion growth; 18-month...

March 31, 2023, 11:03 pm

belite bio to host webcast on april 3, 2023 to discuss 2022 full year financial results

SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) — belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinic...

March 31, 2023, 4:57 pm

belite bio to host webcast on april 3, 2023 to discuss 2022 full year financial results

SAN DIEGO, March 31, 2023 (GLOBE NEWSWIRE) -- belite Bio, Inc (NASDAQ: BLTE), a San Diego based clinica...

March 31, 2023, 12:57 pm


Search within

Pages Search Results: